OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dapagliflozin alleviates renal podocyte pyroptosis via regulation of the HO‑1/NLRP3 axis
Zhenwang Zhang, Ping Ni, Ming-Qiu Tang, et al.
Molecular Medicine Reports (2023) Vol. 28, Iss. 5
Open Access | Times Cited: 13
Zhenwang Zhang, Ping Ni, Ming-Qiu Tang, et al.
Molecular Medicine Reports (2023) Vol. 28, Iss. 5
Open Access | Times Cited: 13
Showing 13 citing articles:
Dapagliflozin prevents kidney podocytes pyroptosis via miR-155-5p/HO-1/NLRP3 axis modulation
Zhen-wang Zhang, Ming-Qiu Tang, Wu Liu, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111785-111785
Closed Access | Times Cited: 8
Zhen-wang Zhang, Ming-Qiu Tang, Wu Liu, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111785-111785
Closed Access | Times Cited: 8
Recent advances in understanding the mechanisms by which sodium-glucose co-transporter type 2 inhibitors protect podocytes in diabetic nephropathy
Xinqi Chen, Mingjie Wang, Zhaoli Yan
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Xinqi Chen, Mingjie Wang, Zhaoli Yan
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Current landscape of fecal microbiota transplantation in treating depression
Qi Zhang, Yajun Bi, Boyu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Qi Zhang, Yajun Bi, Boyu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Resveratrol ameliorates ulcerative colitis by upregulating Nrf2/HO‑1 pathway activity: Integrating animal experiments and network pharmacology
YU Xin-ya, Xiaoxi Li, Yunchun Xu, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 6
YU Xin-ya, Xiaoxi Li, Yunchun Xu, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 6
Podocyte programmed cell death in diabetic kidney disease: Molecular mechanisms and therapeutic prospects
Haoyu Yang, Jun Sun, Aru Sun, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117140-117140
Closed Access | Times Cited: 5
Haoyu Yang, Jun Sun, Aru Sun, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117140-117140
Closed Access | Times Cited: 5
Glycosphingolipids-Dependent Phospholipid Metabolism Enhances Cancer Initiation and Progression through SMPD1/GLTP/B3GALT4/ST8SIA6 Signaling Axis: A Novel Therapeutic Target
Liangpan Shi, Nanqi Mao, Zhihua Zheng, et al.
International Journal of Medical Sciences (2025) Vol. 22, Iss. 3, pp. 604-615
Open Access
Liangpan Shi, Nanqi Mao, Zhihua Zheng, et al.
International Journal of Medical Sciences (2025) Vol. 22, Iss. 3, pp. 604-615
Open Access
Dapagliflozin attenuates skeletal muscle atrophy in diabetic nephropathy mice through suppressing Gasdermin D-mediated pyroptosis
Yulong Zhang, Shuang Guo, Pengyu Wang, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114088-114088
Closed Access
Yulong Zhang, Shuang Guo, Pengyu Wang, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114088-114088
Closed Access
The SGLT2 inhibitor dapagliflozin suppresses endothelial cell pyroptosis mediated by the NF-κB/NLRP3 pathway through downregulation of CTSB
Quanwei Zhao, Hui Li, Danan Liu, et al.
Biochemical Pharmacology (2025) Vol. 236, pp. 116857-116857
Closed Access
Quanwei Zhao, Hui Li, Danan Liu, et al.
Biochemical Pharmacology (2025) Vol. 236, pp. 116857-116857
Closed Access
Repurposing Secukinumab and Dapagliflozin as Candidate Therapies to Mitigate the Renal Toxicity of Sunitinib in Rats Through Suppressing IL‐17‐Mediated Pyroptosis and Promoting Autophagy
Rania A. Elrashidy, Hoda E. Mohamad, Sara M. Abdel Aal, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
Rania A. Elrashidy, Hoda E. Mohamad, Sara M. Abdel Aal, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
Role of the Innate Immune Response in Glomerular Disease Pathogenesis: Focus on Podocytes
Wadih Issa, Rachel Njeim, Arianna Carrazco, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1157-1157
Open Access | Times Cited: 3
Wadih Issa, Rachel Njeim, Arianna Carrazco, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1157-1157
Open Access | Times Cited: 3
Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy
Fengzhao Liu, Zhenyu Yang, Jixin Li, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Fengzhao Liu, Zhenyu Yang, Jixin Li, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Swollen Feet: Considering the Paradoxical Roles of Interleukins in Nephrotic Syndrome
Maria E. Kovalik, Monique A. Dacanay, Steven D. Crowley, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 738-738
Open Access
Maria E. Kovalik, Monique A. Dacanay, Steven D. Crowley, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 738-738
Open Access
Modulating mitochondrial dynamics ameliorates left ventricular dysfunction by suppressing diverse cell death pathways after diabetic cardiomyopathy
Fumin Zhi, Xiangyi Pu, Wei Wei, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 12, pp. 2324-2333
Open Access
Fumin Zhi, Xiangyi Pu, Wei Wei, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 12, pp. 2324-2333
Open Access
